Erasca
Established in 2018, Erasca is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.
Last updated on
About Erasca
Founded
2018Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$564MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
87NAICs Code
54Location
City
San DiegoState
CaliforniaCountry
United StatesTech Stack (70)
